BINDING OF FANTOFARONE, A NOVEL CA2+ ANTAGONIST, TO SERUM-ALBUMIN - A FLUORESCENCE STUDY

被引:9
作者
CHATELAIN, P
MATTEAZZI, JR
LARUEL, R
机构
[1] Sanofi-Pharma Research Centre, Brussels, B-1120, avenue de Béjar
关键词
D O I
10.1002/jps.2600830516
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using the fluorescent properties of fantofarone, we have studied the interactions between this novel calcium entry blocker and human and bovine serum albumins. Binding of fantofarone, which is poorly fluorescent in aqueous buffer, resulted in a large increase in the fluorescent signal (lambda(ex) = 335 nm, lambda(em) = 395 nm). Fantofarone bound to a single site with a dissociation constant (K-d) of 11-12 X 10(-6) M. The number of sites and the K-d value were not modified by either NaCl (134 mM) or Ca2+ (10 mM). Two values of fluorescence lifetime (tau(1) = 12.8 ns and tau(2) = 3.5 nS) with respective fractional contributions (chi(1) = 0.79 and chi(2) = 0.21) were determined. Quenching by iodide resulted in a downward curved Stern-Volmer plot, where 36% of the fluorescence was quenched with a quenching constant (K-Q) of 11.4 M(-1), From the measured degree of fluorescence depolarization and fluorescence lifetime, a value of rotational relaxation time of 109 ns was calculated.
引用
收藏
页码:674 / 676
页数:3
相关论文
共 21 条
  • [1] THE USE OF ISOCHRONAL REFERENCE-STANDARDS IN PHASE AND MODULATION FLUORESCENCE LIFETIME MEASUREMENTS
    BARROW, DA
    LENTZ, BR
    [J]. JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1983, 7 (03): : 217 - 234
  • [2] AMIODARONE INDUCED MODIFICATIONS OF THE PHOSPHOLIPID PHYSICAL STATE - A FLUORESCENCE POLARIZATION STUDY
    CHATELAIN, P
    FERREIRA, J
    LARUEL, R
    RUYSSCHAERT, JM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (18) : 3007 - 3013
  • [3] FLUORESCENT STUDIES ON THE INTERACTION BETWEEN A NOVEL CA-2+ ANTAGONIST, SR-33557, AND MEMBRANE-LIPIDS
    CHATELAIN, P
    MATTEAZZI, JR
    LARUEL, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 43 (07) : 1513 - 1520
  • [4] SR-33557 - A SLOW CALCIUM-CHANNEL ANTAGONIST WITH A NOVEL SITE OF ACTION
    CHATELAIN, P
    GUBIN, J
    MANNING, AS
    SISSMAN, J
    [J]. CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (02): : 123 - 146
  • [5] CHATELAIN P, 1991, MOL PHARMACOL, V39, P64
  • [6] EXPOSURE OF TRYPTOPHANYL RESIDUES IN PROTEINS - QUANTITATIVE-DETERMINATION BY FLUORESCENCE QUENCHING STUDIES
    EFTINK, MR
    GHIRON, CA
    [J]. BIOCHEMISTRY, 1976, 15 (03) : 672 - 680
  • [7] FLUORESCENCE QUENCHING STUDIES WITH PROTEINS
    EFTINK, MR
    GHIRON, CA
    [J]. ANALYTICAL BIOCHEMISTRY, 1981, 114 (02) : 199 - 227
  • [8] HSU P, 1974, J PHARM SCI, V63, P27, DOI 10.1002/jps.2600630107
  • [9] DRUG-THERAPY - BINDING OF DRUGS TO SERUM-ALBUMIN .1.
    KOCHWESER, J
    SELLERS, EM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (06) : 311 - 316
  • [10] DRUG-THERAPY .2. BINDING OF DRUGS TO SERUM-ALBUMIN
    KOCHWESER, J
    SELLERS, EM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (10) : 526 - 531